BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 61 filers reported holding BEAM THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,676,911 | -5.0% | 69,726 | +26.2% | 0.00% | 0.0% |
| Q2 2023 | $1,764,548 | +2.6% | 55,263 | -1.6% | 0.00% | 0.0% |
| Q1 2023 | $1,719,434 | -17.4% | 56,154 | +5.5% | 0.00% | 0.0% |
| Q4 2022 | $2,081,629 | -18.9% | 53,225 | -1.2% | 0.00% | 0.0% |
| Q3 2022 | $2,567,000 | +17.3% | 53,884 | -4.7% | 0.00% | 0.0% |
| Q2 2022 | $2,188,000 | -10.5% | 56,524 | +32.5% | 0.00% | 0.0% |
| Q1 2022 | $2,445,000 | -20.1% | 42,661 | +11.1% | 0.00% | 0.0% |
| Q4 2021 | $3,059,000 | -5.5% | 38,386 | +3.2% | 0.00% | 0.0% |
| Q3 2021 | $3,237,000 | -14.2% | 37,207 | +27.0% | 0.00% | 0.0% |
| Q2 2021 | $3,771,000 | +87.1% | 29,303 | +16.3% | 0.00% | 0.0% |
| Q1 2021 | $2,016,000 | +201.3% | 25,195 | +207.2% | 0.00% | – |
| Q4 2020 | $669,000 | +443.9% | 8,201 | +64.3% | 0.00% | – |
| Q3 2020 | $123,000 | +59.7% | 4,991 | +82.8% | 0.00% | – |
| Q2 2020 | $77,000 | +126.5% | 2,731 | +43.2% | 0.00% | – |
| Q1 2020 | $34,000 | – | 1,907 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HSG Holding Ltd | 1,127,934 | $31,582,000 | 5.60% |
| Omega Fund Management, LLC | 302,821 | $8,479,000 | 2.32% |
| Redmile Group, LLC | 3,356,958 | $93,995,000 | 1.74% |
| BRANDYWINE MANAGERS, LLC | 10,875 | $305,000 | 1.25% |
| DC Investments Management, LLC | 88,100 | $2,467,000 | 0.91% |
| Alphabet Inc. | 663,691 | $18,583,000 | 0.86% |
| Cormorant Asset Management, LP | 796,429 | $22,036,000 | 0.84% |
| HHLR ADVISORS, LTD. | 2,966,403 | $83,059,000 | 0.76% |
| Temasek Holdings (Private) Ltd | 3,354,641 | $93,930,000 | 0.56% |
| Granahan Investment Management | 96,598 | $2,705,000 | 0.10% |